# Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain

> **NCT02228928** · PHASE1,PHASE2 · COMPLETED · sponsor: **Samyang Biopharmaceuticals Corporation** · enrollment: 60 (actual)

## Conditions studied

- Peripheral Nerve Injury
- Postherpetic Neuralgia

## Interventions

- **DRUG:** CAPNP, 50 ug/cm2 capsaicin patch
- **DRUG:** CAPNP, 100 ug/cm2 capsaicin patch
- **DRUG:** 0.075% capsaicin cream
- **OTHER:** Placebo patch

## Key facts

- **NCT ID:** NCT02228928
- **Lead sponsor:** Samyang Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228928, "Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02228928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*